Codexis Inc.

23.12-0.4800-2.03%Vol 216.50K1Y Perf 113.80%
Apr 19th, 2021 15:29 DELAYED
BID23.10 ASK23.15
Open23.31 Previous Close23.60
Pre-Market- After-Market-
 - -%  - -
Target Price
27.71 
Analyst Rating
Strong Buy 1.00
Potential %
19.29 
Finscreener Ranking
★★★★+     57.84
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★+     54.45
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★     52.06
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Market Cap1.49B 
Earnings Rating
Sell
Price Range Ratio 52W %
66.60 
Earnings Date
6th May 2021

Today's Price Range

22.5923.62

52W Range

10.2829.56

5 Year PE Ratio Range

-57.60-26.30

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
-1.67%
1 Month
6.59%
3 Months
-6.72%
6 Months
67.73%
1 Year
113.80%
3 Years
107.93%
5 Years
532.71%
10 Years
126.92%

TickerPriceChg.Chg.%
CDXS23.12-0.4800-2.03
AAPL134.340.18000.13
GOOG2 298.961.20000.05
MSFT258.40-2.3400-0.90
XOM56.22-0.4400-0.78
WFC43.870.03000.07
JNJ162.610.37000.23
FB301.16-5.0200-1.64
GE13.410.02000.15
JPM152.78-0.5200-0.34
Financial StrengthValueIndustryS&P 500US Markets
7.20
7.40
0.12
0.15
-
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
80.10
-34.60
-28.00
-23.50
-29.41
RevenueValueIndustryS&P 500US Markets
54.39M
0.84
7.74
10.75
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.13-0.0653.85
Q03 2020-0.16-0.1037.50
Q02 2020-0.25-0.1156.00
Q01 2020-0.15-0.1313.33
Q04 2019-0.01-0.010.00
Q03 2019-0.090.01111.11
Q02 2019-0.08-0.12-50.00
Q01 2019-0.09-0.090.00
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.20-25.00Negative
6/2021 QR-0.140.00-
12/2021 FY-0.61-17.31Negative
12/2022 FY-0.50-28.21Negative
Next Report Date6th May 2021
Estimated EPS Next Report-0.20
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume216.50K
Shares Outstanding64.40M
Trades Count3.90K
Dollar Volume17.34M
Avg. Volume696.52K
Avg. Weekly Volume338.02K
Avg. Monthly Volume633.93K
Avg. Quarterly Volume700.00K

Codexis Inc. (NASDAQ: CDXS) stock closed at 23.6 per share at the end of the most recent trading day (a -3.87% change compared to the prior day closing price) with a volume of 330.39K shares and market capitalization of 1.49B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 161 people. Codexis Inc. CEO is John J. Nicols.

The one-year performance of Codexis Inc. stock is 113.8%, while year-to-date (YTD) performance is 8.11%. CDXS stock has a five-year performance of 532.71%. Its 52-week range is between 10.28 and 29.56, which gives CDXS stock a 52-week price range ratio of 66.60%

Codexis Inc. currently has a PE ratio of -61.60, a price-to-book (PB) ratio of 9.32, a price-to-sale (PS) ratio of 27.79, a price to cashflow ratio of 1 242.70, a PEG ratio of 2.32, a ROA of -12.51%, a ROC of -17.32% and a ROE of -16.85%. The company’s profit margin is -29.41%, its EBITDA margin is -28.00%, and its revenue ttm is $54.39 Million , which makes it $0.84 revenue per share.

Of the last four earnings reports from Codexis Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.20 for the next earnings report. Codexis Inc.’s next earnings report date is 06th May 2021.

The consensus rating of Wall Street analysts for Codexis Inc. is Strong Buy (1), with a target price of $27.71, which is +19.29% compared to the current price. The earnings rating for Codexis Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Codexis Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Codexis Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 20.70, ATR14 : 1.72, CCI20 : 36.90, Chaikin Money Flow : 0.10, MACD : -0.31, Money Flow Index : 69.91, ROC : 12.06, RSI : 38.95, STOCH (14,3) : 65.40, STOCH RSI : 0.72, UO : 46.24, Williams %R : -34.60), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Codexis Inc. in the last 12-months were: Bernard J. Kelley (Option Excercise at a value of $210 200), Bernard J. Kelley (Sold 30 000 shares of value $530 211 ), Bernard Kelley (Sold 15 000 shares of value $214 276 ), Byron Dorgan (Option Excercise at a value of $1 063 000), Byron Dorgan (Sold 100 000 shares of value $1 973 695 ), Dennis P. Wolf (Sold 50 000 shares of value $740 458 ), Thomas R. Baruch (Sold 9 894 shares of value $104 929 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (100.00 %)
4 (100.00 %)
4 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Codexis Inc.

Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins and developing biocatalyst products. The firm's products and services include Screening and Evolution services, Enzymes, Screening Kits. It also develops protein engineering and biocatalyst platforms such as Codeevolver, Ketoreductases, Transminases, Imine reductases etc. The company operates in two business segment namely Performance Enzymes and Novel Biotherapeutics.

CEO: John J. Nicols

Telephone: +1 650 421-8100

Address: 200 Penobscot Drive, Redwood City 94063, CA, US

Number of employees: 161

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

46%54%

Bearish Bullish

52%48%

Bearish Bullish

56%44%

News

Stocktwits